D-068

Duloxetine-D₃ hydrochloride solution

100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant^®

• Formule empirique (notation de Hill): C₁₈D₃H₁₆NOS · HCl
• Poids moléculaire : 336.89
• Numéro CE : 200-659-6
• Numéro MDL: MFCD09752117
• Code UNSPSC : 41116107
• ID de substance PubChem : 329798627
• Nomenclature NACRES : NA.24

Propriétés

• Qualité: certified reference material
• Niveau de qualité: 300
• Forme: liquid
• Caractéristiques: Snap-N-Spike^®/Snap-N-Shoot^®
• Conditionnement: ampule of 1 mL
• Fabricant/nom de marque: Cerilliant^®
• Concentration: 100 μg/mL in methanol (as free base)
• Technique(s): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Application(s): clinical testing
• Format: single component solution
• Température de stockage: −20°C
• Chaîne SMILES: Cl.[2H]C([2H])([2H])NCC[C@H](Oc1cccc2ccccc12)c3cccs3
• InChI: 1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1/i1D3;
• Clé InChI: BFFSMCNJSOPUAY-HQKLNPQUSA-N

Description

Description générale

A stable-labeled internal standard suitable for numerous GC/MS and LC/MS applications from clinical toxicology and urine drug testing to forensic analysis and isotope dilution methods. Duloxetine, marketed in the US under the trade name Cymbalta^®, is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder and to alleviate pain associated with diabetic neuropathy, fibromyalgia, and osteoarthritis.

Application

• Rapid Structure-Based Screening for COVID-19: Duloxetine-D₃ hydrochloride solution plays a key role in rapid structure-based screening, potentially informing the development of therapeutic agents for COVID-19 due to its properties as a serotonin-norepinephrine reuptake inhibitor, crucial for high-impact pharmaceutical research (Yang et al., 2020).


• UV-Triggered Drug Release: The high-purity Duloxetine-D₃ solution enhances UV-triggered drug release studies from mesoporous titanium nanoparticles loaded with pharmaceutical agents, indicating significant benefits for developing controlled drug delivery systems in biotechnological applications (Zuo et al., 2024).


• Antioxidant Activity and Eczema Treatment: Duloxetine-D₃ HCl serves as an internal standard in studies evaluating the antioxidant activities and therapeutic applications of drug-loaded liposomes for eczema treatment, highlighting its role in enhancing bioanalytical assay development (Shen et al., 2024).


• Synthesis and Application of EGFR Inhibitors for Cancer: As a stable isotope-labeled compound, Duloxetine-D₃ hydrochloride is used in the synthesis and clinical application studies of small-molecule EGFR inhibitors, underlining its critical application in cancer therapy research (Wang et al., 2024).


• Nanoparticle Drug Release Behaviors: The solution′s role in studying poly(lactic-co-glycolic acid) nanoparticles highlights its utility in pharmaceutical-grade calibration for analyzing hydrophilic and hydrophobic drug release behaviors, essential for pharmaceutical and biomedical research (Wang et al., 2024).

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Cymbalta is a registered trademark of Eli Lilly and Co.

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Informations sur la sécurité

• Pictogrammes: GHS02,GHS06,GHS08
• Mention d'avertissement: Danger
• Mentions de danger: H225,H301 + H311 + H331,H370
• Conseils de prudence: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• Classification des risques: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Organes cibles: Eyes
• Code de la classe de stockage: 3 - Flammable liquids
• Classe de danger pour l'eau (WGK): WGK 1
• Point d'éclair (°F): 49.5 °F - closed cup
• Point d'éclair (°C): 9.7 °C - closed cup